2 No-Brainer Artificial Intelligence (AI) Stocks to Buy With $450 in June 2025
Software stocks have outperformed hardware stocks year to date, and that trend will likely continue because investors are nervous about tariffs.
Snowflake is a leader in database management systems, and the company has rolled out several artificial intelligence features during the last two years.
Okta is a leader in identity and access management, and the company recently added an AI-powered threat protection product to its already-robust portfolio.
10 stocks we like better than Snowflake ›
Within the technology sector, software stocks have outperformed hardware stocks by 26 percentage points year to date. Software companies are more attractive in the current market environment (particularly those involved with artificial intelligence) because they are generally exempt from tariffs.
Investors can lean into that trend with Snowflake (NYSE: SNOW) and Okta (NASDAQ: OKTA). Both stocks handily beat the broader software industry through the first five months of 2025, and most Wall Street analysts anticipated more upside in the next year.
Among the 50 analysts that follow Snowflake, the median target price is $222 per share. That implies 8% upside from the current share price of $205.
Among the 47 analysts that follow Okta, the median target price is $130 per share. That implies 26% upside from the current share price of $103.
Investors with $450 to spend should consider spreading the money evenly across Snowflake and Okta. Here's why.
Snowflake specializes in analytics. Its cloud platform lets customers unify and make sense of data, share and monetize datasets, and develop artificial intelligence (AI) models and data-driven applications. Consultancy Gartner recently recognized the company as a technology leader in database management systems.
Snowflake has introduced numerous artificial intelligence features during the last two years. Cortex AI is a fully managed service (inclusive of a custom large language model called Arctic) that can understand data, summarize information, and answer questions in natural language. Snowflake has also added AI tools for anomaly detection, classification, and forecasting.
Snowflake reported strong financial results in the first quarter of fiscal 2026, which ended in April. Total customers increased 18% to 11,578 and the average existing customer spent 24% more. In turn, revenue rose 26% to $1 billion, and non-GAAP net income jumped 71% to $0.24 per diluted share. The company also raised full-year guidance, such that revenue is projected to increase 25%.
Looking ahead, Snowflake values its total addressable market at $342 billion by 2028. Wall Street expects adjusted earnings to grow at 35% annually through fiscal 2027, which ends in January 2027. That makes the current valuation of 222 times earnings seem absurd. But analysts have consistently underestimated the company. Snowflake topped the consensus earnings estimate by an average of 34% in the last six quarters.
Admittedly, Snowflake stock would still be expensive today even if that trend continues, but I think long-term investors can buy a very small position right now and add more shares as better opportunities present themselves.
Okta specializes in identity and access management (IAM) software. IAM is a cybersecurity framework that lets administrators set system permissions, so only specified users and devices can access applications and resources. Its platform leans on AI to authenticate users and (thanks to a recently released threat protection product) continuously assess risk. Gartner has ranked Okta as an industry leader for eight consecutive years.
Importantly, Okta provides solutions for customer identity and workforce identity, and it supplements its core IAM solutions with privileged access management (PAM) and identity governance and administration (IGA) products. The former protects highly privileged (superuser) accounts and the latter simplifies compliance reporting and automates IAM workflows.
Okta reported solid results in the first quarter of fiscal 2026, which ended in April, beating estimates on the top and bottom lines. Revenue rose 12% to $688 million and non-GAAP net income increased 32% to $0.86 per diluted share. But the stock plunged following the report because management chose not to raise full-year guidance, citing macroeconomic uncertainty.
Looking ahead, Okta values its addressable market at $80 billion. Wall Street estimates earnings will increase at 10% annually through fiscal 2027, which ends in January 2027. That makes the current valuation of 33 times earnings look rather expensive, but I believe analysts are underestimating the company as they have in the past.
Okta beat the consensus earnings estimate by an average 15% in the last six quarters. I believe that trend will continue. IAM spending is forecast to increase at 12.6% annually through 2030, which means Okta can beat the consensus earnings estimate if it merely keeps pace with the market. Investors should feel comfortable buying a small position in this stock right now.
Before you buy stock in Snowflake, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Snowflake wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $651,049!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $828,224!*
Now, it's worth noting Stock Advisor's total average return is 979% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of June 2, 2025
Trevor Jennewine has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Okta and Snowflake. The Motley Fool recommends Gartner. The Motley Fool has a disclosure policy.
2 No-Brainer Artificial Intelligence (AI) Stocks to Buy With $450 in June 2025 was originally published by The Motley Fool

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
11 minutes ago
- Associated Press
The Joint Corp. Announces $5 Million Stock Repurchase Program
SCOTTSDALE, Ariz., June 05, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that its board of directors has authorized a stock repurchase program expected to begin in August 2025 under which the company may repurchase up to $5 million of its outstanding common stock. 'The stock buyback reflects the board's confidence in our long-term strategy, refranchising program and our projected cash flow generation,' said Sanjiv Razdan, chief executive officer, president and director of The Joint Corp. 'We believe our franchise model and long-term valuation are not yet fully recognized in our current stock price. This stock repurchase program underscores our commitment to disciplined capital allocation and delivering value to our stockholders.' Repurchases may be made from time to time in open market transactions, privately negotiated transactions, or by other means, in accordance with applicable securities laws and subject to market conditions and other factors. The timing, number and amount of any repurchases will be determined by the company's finance committee of the board of directors at its discretion. The stock repurchase program does not obligate the company to acquire any particular amount of common stock, has a termination date of June 3, 2027 and may be suspended or discontinued at any time. About The Joint Corp. (NASDAQ: JYNT) The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation's largest operator, manager and franchisor of chiropractic clinics through The Joint Chiropractic network. The company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. Headquartered in Scottsdale, with over 950 locations nationwide and more than 14 million patient visits annually, The Joint Chiropractic is a key leader in the chiropractic industry. The brand is consistently named to Franchise Times' annual 'Top 400' and 'Fast & Serious' list of 40 smartest growing brands. Entrepreneur named The Joint 'No. 1 in Chiropractic Services,' and is regularly ranked on the publication's 'Franchise 500,' the 'Fastest-Growing Franchises,' the 'Best of the Best' lists, as well as its 'Top Franchise for Veterans' and 'Top Brands for Multi-Unit Owners.' SUCCESS named the company as one of the 'Top 50 Franchises' in 2024. The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit To learn about franchise opportunities, visit Business Structure The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington, and West Virginia, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices. Forward-Looking Statements This press release contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. Words such as, 'anticipates,' 'believes,' 'continues,' 'estimates,' 'expects,' 'goal,' 'objectives,' 'intends,' 'may,' 'opportunity,' 'plans,' 'potential,' 'near-term,' 'long-term,' 'projections,' 'assumptions,' 'projects,' 'guidance,' 'forecasts,' 'outlook,' 'target,' 'trends,' 'should,' 'could,' 'would,' 'will,' and similar expressions are intended to identify such forward-looking statements. Specific forward-looking statements made in this press release include, among others, our belief that the stock buyback reflects the board's confidence in our long-term strategy, refranchising program and our projected cash flow generation; that our franchise model and long-term valuation are not yet fully recognized in our current stock price, and that the stock repurchase program underscores our commitment to disciplined capital allocation and delivering value to our stockholders. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any forward-looking statements, and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, our inability to identify and recruit enough qualified chiropractors and other personnel to staff our clinics, due in part to the nationwide labor shortage and an increase in operating expenses due to measures we may need to take to address such shortage; inflation, which has increased our costs and which could otherwise negatively impact our business; our failure to profitably operate company-owned or managed clinics; our failure to refranchise as planned; short-selling strategies and negative opinions posted on the internet, which could drive down the market price of our common stock and result in class action lawsuits; our failure to remediate future material weaknesses in our internal control over financial reporting, which could negatively impact our ability to accurately report our financial results, prevent fraud, or maintain investor confidence; and other factors described in our filings with the SEC, including in the section entitled 'Risk Factors' in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 14, 2025 and subsequently filed current and quarterly reports. We qualify any forward-looking statements entirely by these cautionary factors. We assume no obligation to update or revise any forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data. Media Contact: Margie Wojciechowski, The Joint Corp., [email protected] Investor Contact: Kirsten Chapman, Alliance Advisors IR, 415-433-3777, [email protected]


Associated Press
11 minutes ago
- Associated Press
Trane Technologies Honored for Outstanding Corporate Citizenship With Inclusion on The Civic 50
SWORDS, Ireland, June 4, 2025 /3BL/ - Trane Technologies (NYSE:TT), a global climate innovator, has been recognized as one of the most community-minded companies in the United States by being included on The Civic 50. For over a decade, this prestigious list, curated by Points of Light, has set the standard for corporate citizenship, highlighting how top companies integrate social impact and community engagement into the core of their business operations. 'We are deeply honored to receive this prestigious recognition from Points of Light,' said Deidra Parrish Williams, Trane Technologies' leader of Citizenship and Community Engagement and Executive Director, Trane Technologies Foundation. 'We are committed to creating a sustainable future that strengthens our industry, protects our planet, and empowers the next generation of leaders to transform the world. Being named to The Civic 50 is a testament to years of dedication to this work, and to the thousands of employees around the world who bring our commitments to life by engaging in their communities.' 'In an ever-evolving landscape, companies are looking to ensure that they can meet the needs of their communities, customers, and stakeholders,' said Jennifer Sirangelo, president and CEO, Points of Light. 'Companies like Trane Technologies are leading the way in showing how social impact benefits their employees' well-being, strengthens the communities where they do business, and brings value and meaning to their work. Their efforts provide a model for others looking to bring the benefits of volunteering and social impact to their workforce and they're extremely deserving of this recognition.' Trane Technologies is paving the way with its corporate citizenship strategy, Sustainable Futures, which focuses on broadening access to STEM education and career pathways. This includes a commitment to invest $100 million and 500,000 volunteer hours in building sustainable futures in our communities over ten years from 2020 to 2030. Last year, over a thousand Trane Technologies employees participated in a Global Time of Service event, contributing approximately 3,200 volunteer hours over a period of a few weeks to various causes. Learn about our community impact in our 2024 Sustainability Report. # # # About Trane TechnologiesTrane Technologies is a global climate innovator. Through our strategic brands Trane® and Thermo King®, and our portfolio of environmentally responsible products and services, we bring efficient and sustainable climate solutions to buildings, homes and transportation. Visit The Trane Technologies Charitable FoundationThe Trane Technologies Charitable Foundation is a philanthropic 501(c)3 established and funded by the company to act as its primary philanthropic vehicle. As such, its focus is on developing non-profit relationships that specifically advance its corporate citizenship strategy, Sustainable Futures, which focuses on broadening access to Science, Technology, Engineering and Mathematics (STEM) education and green careers. Through the Foundation and other philanthropic initiatives, Trane Technologies has pledged to invest $100 million to this work by 2030 and we are on track to Points of LightPoints of Light is a nonpartisan, global nonprofit organization that inspires, equips, and mobilizes millions of people to take action that creates a positive impact through volunteering and civic engagement. Through partnerships with nonprofits, companies and social impact leaders, the organization galvanizes volunteers to meet critical needs for healthier and more resilient communities. As the world's largest organization dedicated to increasing volunteer service, Points of Light engages more than 3.8 million volunteers across 32 countries. For more information, visit


Associated Press
11 minutes ago
- Associated Press
Liminatus Pharma Announces Compliance with Nasdaq Filing Requirements
La Palma, CA June 04, 2025 --( )-- Liminatus Pharma, Inc. (Nasdaq: LIMN) ('Liminatus' or the 'Company'), a pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies, today announced that on June 3, 2025, it received a notification letter from Nasdaq indicating that it now complies with Nasdaq Listing Rule 5250(c)(1) which requires timely filing of reports with the U.S. Securities and Exchange Commission and the matter is now closed. Prior to its filing on June 2, 2025, the Company had received a notification letter from Nasdaq on May 29, 2025, stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2025. On June 2, 2025, the Company filed the Form 10-Q such that it is now current with respect to its Exchange Act reporting obligations. About Liminatus Liminatus Pharma, Inc. is pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies. The Company's candidate IBA101, is a humanized anti CD47 monoclonal antibody. The next generation CD47 checkpoint inhibitor's initial indication is expected to be patients with advanced solid cancers including non-small cell lung cancer. The Company's vision is to develop a broad array of transformative therapies for cancer patients as a leading global biopharmaceutical company. For more information, please contact: Chris Kim, Chief Executive Officer [email protected] Contact Information: Liminatus Pharma, Inc Chris Kim 2132-735-453 Contact via Email Read the full story here: Liminatus Pharma Announces Compliance with Nasdaq Filing Requirements Press Release Distributed by